OptiNose, Inc. (OPTN)
NASDAQ: OPTN · Real-Time Price · USD
0.670
-0.006 (-0.90%)
Nov 4, 2024, 4:00 PM EST - Market closed
OptiNose Employees
OptiNose had 132 employees as of December 31, 2023. The number of employees decreased by 9 or -6.38% compared to the previous year.
Employees
132
Change (1Y)
-9
Growth (1Y)
-6.38%
Revenue / Employee
$568,621
Profits / Employee
-$309,909
Market Cap
101.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FONAR | 561 |
Harvard Bioscience | 416 |
MDxHealth | 300 |
Adicet Bio | 143 |
BioAtla | 65 |
Assertio Holdings | 53 |
Relmada Therapeutics | 20 |
Genenta Science | 14 |
OPTN News
- 19 days ago - Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Optinose Appoints Terry Kohler as Chief Financial Officer - GlobeNewsWire
- 2 months ago - New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery - GlobeNewsWire
- 2 months ago - Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - OptiNose, Inc. (OPTN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Optinose Announces Reporting Date for Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Expanded Access to XHANCE with Addition to National Commercial Formularies - GlobeNewsWire
- 6 months ago - OptiNose, Inc. (OPTN) Q1 2024 Earnings Call Transcript - Seeking Alpha